nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Angiogenesis-Targeted Therapies in Prostate Cancer
|
Lara Jr, Primo N. |
|
2004 |
|
3 |
p. 165-173 9 p. |
artikel |
2 |
Beyond PSA: A Need for Additional Markers for Prostate Cancer
|
Sartor, Oliver |
|
2004 |
|
3 |
p. 135- 1 p. |
artikel |
3 |
Clinical Strategies in the Management of Biochemical Recurrence After Radical Prostatectomy
|
Zimmerman, Robert A. |
|
2003 |
|
3 |
p. 160-166 7 p. |
artikel |
4 |
Comparison of Total Prostate-Specific Antigen and Derivative Levels in a Screening Population of Black, White, and Korean-American Men
|
Park, Jae |
|
2003 |
|
3 |
p. 173-176 4 p. |
artikel |
5 |
Complications of Androgen-Deprivation Therapy for Prostate Cancer
|
Holzbeierlein, Jeffrey M. |
|
2003 |
|
3 |
p. 147-152 6 p. |
artikel |
6 |
Early Use of Chemotherapy in Conjunction with Radical Prostatectomy
|
Alumkal, Joshi J. |
|
2004 |
|
3 |
p. 144-149 6 p. |
artikel |
7 |
Editorial
|
Sartor, Oliver |
|
2002 |
|
3 |
p. 137- 1 p. |
artikel |
8 |
G Protein–Coupled Receptors Provide Survival Signals in Prostate Cancer
|
Yowell, Charles W. |
|
2002 |
|
3 |
p. 177-181 5 p. |
artikel |
9 |
Highlights from the 29th European Society for Medical Oncology Congress Vienna, Austria October 29 through November 2, 2004
|
Price, Nancy |
|
2004 |
|
3 |
p. 136-140 5 p. |
artikel |
10 |
Highlights from the XII European Cancer Conference; Copenhagen, Denmark, September 21-25, 2003
|
Tyagi, Preeta |
|
2003 |
|
3 |
p. 137-141 5 p. |
artikel |
11 |
Intermittent Versus Continuous Total Androgen Blockade in the Treatment of Patients with Advanced Hormone-Naive Prostate Cancer: Results of a Prospective Randomized Multicenter Trial
|
de Leval, Jean |
|
2002 |
|
3 |
p. 163-171 9 p. |
artikel |
12 |
Ion Channels as Molecular Targets in Prostate Cancer
|
Trepel, Jane B. |
|
2003 |
|
3 |
p. 188-189 2 p. |
artikel |
13 |
Measurement of Intracellular Versus Extracellular Prostate-Specific Antigen Levels in Peripheral Macrophages: A New Approach to Noninvasive Diagnosis of Prostate Cancer
|
Herwig, Ralf |
|
2004 |
|
3 |
p. 184-188 5 p. |
artikel |
14 |
Molecular Markers and Prostate Cancer Prognosis
|
Chin, Jonathan L. |
|
2004 |
|
3 |
p. 157-164 8 p. |
artikel |
15 |
Mutations in Ribonuclease L Gene Do NotOccur at a Greater Frequency in Patients with Familial Prostate Cancer Compared with Patients with Sporadic Prostate Cancer
|
Downing, Sean R. |
|
2003 |
|
3 |
p. 177-180 4 p. |
artikel |
16 |
National Cancer Institute Intramural Approach to Advanced Prostate Cancer
|
Arlen, Philip M. |
|
2002 |
|
3 |
p. 153-162 10 p. |
artikel |
17 |
Newer Therapies in Advanced Prostate Cancer
|
Hegeman, Robert B. |
|
2004 |
|
3 |
p. 150-156 7 p. |
artikel |
18 |
New Treatment Modalities for Hormone-Resistant Prostate Cancer
|
Lee, David |
|
2002 |
|
3 |
p. 139-141 3 p. |
artikel |
19 |
Phase I/II Trial of Bortezomib plus Docetaxel in Patients with Advanced Androgen-Independent Prostate Cancer
|
Price, Nancy |
|
2004 |
|
3 |
p. 141-143 3 p. |
artikel |
20 |
Preliminary Assessment of Magnetic Resonance Spectroscopic Imaging in Predicting Treatment Outcome in Patients with Prostate Cancer at High Risk for Relapse
|
Pucar, Darko |
|
2004 |
|
3 |
p. 174-181 8 p. |
artikel |
21 |
Protease-Activated Receptor 1: A Role in Prostate Cancer Metastasis
|
Yuan, Ta-Chun |
|
2004 |
|
3 |
p. 189-191 3 p. |
artikel |
22 |
Role of Free Prostate-Specific Antigen Measurement in Prostate-Specific Antigen Screening for Prostate Cancer
|
Johnson, Lori |
|
2002 |
|
3 |
p. 142-144 3 p. |
artikel |
23 |
Role of Magnetic Resonance Spectroscopic Imaging in the Prediction of Treatment Outcome in Prostate Cancer
|
Bezabeh, Tedros |
|
2004 |
|
3 |
p. 182-183 2 p. |
artikel |
24 |
The Anti-HER2 Monoclonal Antibody Pertuzumab May Be Effective in Androgen-Independent Prostate Cancer
|
DeGrendele, Heather |
|
2003 |
|
3 |
p. 143-145 3 p. |
artikel |
25 |
The Combination of Antiangiogenic and Cytotoxic Agents in the Treatment of Prostate Cancer
|
Retter, Avi S. |
|
2003 |
|
3 |
p. 153-159 7 p. |
artikel |
26 |
The Design of a Randomized, Placebo-Controlled Trial of Celecoxib in Preprostatectomy Men with Clinically Localized Adenocarcinoma of the Prostate
|
Heath, Elisabeth I. |
|
2002 |
|
3 |
p. 182-187 6 p. |
artikel |
27 |
The Pursuit of Prostate Cancer in Patients with a Rising Prostate-Specific Antigen and Multiple Negative Transrectal Ultrasound-Guided Prostate Biopsies
|
Pryor, Michael B. |
|
2002 |
|
3 |
p. 172-176 5 p. |
artikel |
28 |
Therapeutic Approaches Targeting Prostate Cancer Progression Using Novel Voltage-Gated Ion Channel Blockers
|
Sikes, Robert A. |
|
2003 |
|
3 |
p. 181-187 7 p. |
artikel |
29 |
Weekly Docetaxel in Elderly Patients with Prostate Cancer: Efficacy and Toxicity in Patients Aged ≥ 70 Years Compared with Patients Aged < 70 Years
|
Beer, Tomasz M. |
|
2003 |
|
3 |
p. 167-172 6 p. |
artikel |
30 |
Zoledronic Acid Significantly Reduces Pathologic Fractures in Patients with Advanced-Stage Prostate Cancer Metastatic to Bone
|
Saad, Fred |
|
2002 |
|
3 |
p. 145-152 8 p. |
artikel |